| 428. | Hawro, T., Prybyłowicz, K., Spindler, M., Hawro, M., Steć, M., Altrichter, S., Weller, K., Magerl, M., Reidel, U., Alarbeed, E., Alraboni, O., Maurer, M.+, and Metz, M.: The characteristics and impact of pruritus in in adult dermatologic patients: a prospective, cross-sectional study. J. Am. Acad. Dermatol. 2021: 84; 691-700. IF: 15.49 |
o.428
| 426. | Lumry, W. R.+, Weller, K., Magerl, M., Banerji, A., Longhurst, H. J., Riedl, M. A., Lewis, H. B., Lu, P., Devercelli, G., Jain, G., and Maurer, M.: Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study. Allergy 2021: 76; 1188-1198. IF: 14.71 |
o.426
| 402. | Bonnekoh, H., Terhorst-Molawi, D., Buttgereit, T., Maurer, M., and Altrichter, S.+: Treatment of severe heat urticaria with omalizumab – report of a case and review of the literature. J. Eur. Acad. Dermatol. Venereol. 2020: 34; 433-531. IF: 6.17 |
o.402
| 401. | Maurer, M.+, Giménez-Arnau, A., Ensina, L. F., Chu, C.-Y., Jaumont, X, and Tassinari, P.: Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results. World Allergy Organ. J. 2020: 13; 100460. IF: 4.08 |
o.401
| 400. | Maurer, M.+, Costa, C., Giménez-Arnau, A., Guillet, G., Labrador-Horrillo, M., Lapeere, H., Meshkova, R., Savic, S., and Chapman-Rothe, N.: Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study. Clin. Exp. Allergy 2020: 50; 1166-1175 IF: 5.02 |
o.400
| 392. | Sommer, R.+, Silva, N., Langenbruch, A., Maurer, M., Staubach, P., and Augustin, M.: Characteristics and determinants of patient burden and needs in the treatment of chronic spontaneous urticaria. Eur. J. Dermatol. 2020: 30; 259-266. IF: 3.33 |
o.392
| 231 | Potter, P., Mitha, E., Barkai, L., Gyorgyl, M., Santamaria, E., Izquierdo, I.+, and Maurer, M.: Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years. Pediatr. Allergy Immunol. 2016: 27; 55-61. IF: 3.77 |
| 240 | Siebenhaar, F.+, von Tschirnhaus, E., Hartmann, K., Rabenhorst, A., Staubach, P., Peveling-Oberhag, A., Wagner, N., Martus, P., Carter, M. C., Metcalfe, D. D., Church, M. K., Maurer, M. and Weller, K.: Development and Validation of the Mastocytosis Quality of Life questionnaire: MC-QoL. Allergy 2016: 71; 869-877. IF: 7.36 |
| 261 | Staubach, P., Metz, M., Chapman-Rothe, N., Sieder, C., Bräutigam, M., Canvin, J., and Maurer, M.+: Effect of omalizumab on angioedema in H1-antihistamine resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial. Allergy 2016: 71; 1135-1144. IF: 7.36 |
| 262 | Weller, K.+, Magerl, M., Peveling-Oberhag, A., Martus, P., Staubach, P., and Maurer, M.: The angioedema quality of life questionnaire (AE-QoL) – assessment of sensitivity to change and minimal clinically important difference. Allergy 2016: 71; 1203-1209. IF: 7.36 |